The relevance of studies on androgen action to prostatic cancer.
D000375:Aging; D000726:Androgen Antagonists; D000728:Androgens / Q000378:metabolism / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D013196:Dihydrotestosterone / Q000378:metabolism; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D006965:Hyperplasia; D008297:Male; D009374:Neoplasms, Experimental / Q000378:metabolism; D011230:Precancerous Conditions / Q000209:etiology; D011467:Prostate / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D011944:Receptors, Androgen / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
D000726:Androgen Antagonists; D000728:Androgens; D004967:Estrogens; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D013739:Testosterone